Plasmin inhibition by bacterial serpin: Implications in gum disease

FASEB J. 2020 Jan;34(1):619-630. doi: 10.1096/fj.201901490RR. Epub 2019 Nov 26.

Abstract

Tannerella forsythia is a periodontopathogen that expresses miropin, a protease inhibitor in the serpin superfamily. In this study, we show that miropin is also a specific and efficient inhibitor of plasmin; thus, it represents the first proteinaceous plasmin inhibitor of prokaryotic origin described to date. Miropin inhibits plasmin through the formation of a stable covalent complex triggered by cleavage of the Lys368-Thr369 (P2-P1) reactive site bond with a stoichiometry of inhibition of 3.8 and an association rate constant (kass) of 3.3 × 105 M-1s-1. The inhibition of the fibrinolytic activity of plasmin was nearly as effective as that exerted by α2-antiplasmin. Miropin also acted in vivo by reducing blood loss in a mice tail bleeding assay. Importantly, intact T. forsythia cells or outer membrane vesicles, both of which carry surface-associated miropin, strongly inhibited plasmin. In intact bacterial cells, the antiplasmin activity of miropin protects envelope proteins from plasmin-mediated degradation. In summary, in the environment of periodontal pockets, which are bathed in gingival crevicular fluid consisting of 70% of blood plasma, an abundance of T. forsythia in the bacterial biofilm can cause local inhibition of fibrinolysis, which could have possible deleterious effects on the tooth-supporting structures of the periodontium.

Keywords: Tannerella forsythia; fibrinolysis; periodontitis; plasmin; serpin.

Publication types

  • Research Support, N.I.H., Extramural
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Antifibrinolytic Agents / pharmacology*
  • Bacteria / metabolism
  • Catalytic Domain
  • Female
  • Fibrinolysin / metabolism
  • Fibrinolysin / pharmacology
  • Fibrinolysis / drug effects*
  • Humans
  • Mice, Inbred C57BL
  • Periodontal Diseases / drug therapy*
  • Protease Inhibitors / pharmacology
  • Serpins / drug effects*
  • Serpins / metabolism

Substances

  • Antifibrinolytic Agents
  • Protease Inhibitors
  • Serpins
  • Fibrinolysin